BINGHAM OSBORN & SCARBOROUGH LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 77 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
BINGHAM OSBORN & SCARBOROUGH LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$142,000
-67.8%
34,516
-80.0%
0.01%
-69.4%
Q2 2020$441,000
-11.4%
172,2020.0%0.04%
-26.5%
Q1 2020$498,000
-49.4%
172,202
-33.8%
0.05%
-38.8%
Q4 2019$985,000
+35.5%
259,963
+83.0%
0.08%
+23.1%
Q3 2019$727,000
-17.5%
142,0630.0%0.06%
-17.7%
Q2 2019$881,000
-15.0%
142,063
-2.6%
0.08%
-17.7%
Q1 2019$1,037,000
-9.4%
145,913
+8.8%
0.10%
-17.9%
Q4 2018$1,145,000
-56.1%
134,108
+3.0%
0.12%
-49.6%
Q3 2018$2,608,000
-22.5%
130,2580.0%0.23%
-27.0%
Q2 2018$3,365,000
+7.5%
130,258
-0.6%
0.32%
+7.4%
Q1 2018$3,131,000
-24.5%
131,004
+7.1%
0.30%
-21.5%
Q4 2017$4,147,000
+60.8%
122,363
+0.4%
0.38%
+56.4%
Q3 2017$2,579,000
+21.0%
121,8300.0%0.24%
+18.1%
Q2 2017$2,131,000
-0.0%
121,8300.0%0.20%
-2.9%
Q1 2017$2,132,000
+7.4%
121,830
+3.7%
0.21%
+0.5%
Q4 2016$1,985,000
-48.5%
117,450
-50.0%
0.21%
-48.8%
Q3 2016$3,855,000
+8.4%
234,9000.0%0.41%
+0.5%
Q2 2016$3,556,000
+719.4%
234,900
+683.0%
0.41%
+696.1%
Q1 2016$434,000
-48.9%
30,0000.0%0.05%
-51.0%
Q4 2015$850,000
+69.3%
30,0000.0%0.10%
+65.1%
Q3 2015$502,000
-36.2%
30,0000.0%0.06%
-33.7%
Q2 2015$787,00030,0000.10%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 657,467$2,709,0002.82%
Healthcare Value Capital, LLC 100,000$412,0001.36%
Opaleye Management Inc. 1,487,800$6,130,0001.20%
Worth Venture Partners, LLC 225,106$927,0000.76%
ARMISTICE CAPITAL, LLC 2,742,000$11,297,0000.41%
DELTEC ASSET MANAGEMENT LLC 355,845$1,466,0000.26%
ESSEX INVESTMENT MANAGEMENT CO LLC 329,437$1,357,0000.19%
Mosaic Family Wealth, LLC 92,357$381,0000.14%
EMERALD ADVISERS, LLC 642,226$2,646,0000.11%
DCF Advisers, LLC 31,236$129,0000.07%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders